Obstructive apneic events induce alpha-receptor mediated digital vasoconstriction

Sleep. 2004 May 1;27(3):485-9. doi: 10.1093/sleep/27.3.485.

Abstract

Study objective: To characterize the role of alpha-receptors in autonomic control of digital skin blood flow change in response to obstructive apnea-hypopnea events.

Design: Experimental intervention study.

Setting: Sleep laboratory in a university hospital.

Patients: Eight male patients with severe obstructive sleep apnea (OSA).

Interventions: Patients received four cumulative dosage steps of phentolamine (0.066, 0.2, 2 and 5 [n=3] microg/min/100 ml forearm tissue) via brachial artery infusion during nonrapid eye movement sleep (stage 1 and 2).

Measurements and results: The pulse amplitude determined with peripheral arterial tonometry (PAT) was periodically attenuated during the immediate post apnea-hypopnea period coinciding with arousal. PAT ratio (smallest pulse amplitude post apnea divided by largest pulse amplitude during apnea), was determined as a measure of digital vasoconstriction. We found that, compared with baseline, PAT ratio dose-dependently increased during phentolamine (0.2, 2 and 5 microg) infusion by 11.2+/-1.7%, 24.4+/-2.1% and 30.9+/-4.1%, respectively (P<0.001). Systemic blood pressure and heart rate were largely unaffected by the pharmacological intervention.

Conclusion: OSA related alteration of the pulse amplitude includes a constriction of digital skin vasculature that to a large extent is mediated via sympathoadrenergic alpha-receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Antagonists / administration & dosage
  • Adrenergic alpha-Antagonists / pharmacology
  • Adult
  • Blood Pressure / drug effects
  • Body Mass Index
  • Electroencephalography
  • Heart Rate / drug effects
  • Humans
  • Injections, Intra-Arterial
  • Male
  • Middle Aged
  • Phentolamine / administration & dosage
  • Phentolamine / pharmacology
  • Polysomnography
  • Receptors, Adrenergic, alpha / drug effects*
  • Receptors, Adrenergic, alpha / metabolism*
  • Signal Processing, Computer-Assisted
  • Sleep Apnea Syndromes / metabolism
  • Sleep Apnea Syndromes / physiopathology
  • Sleep Apnea, Obstructive / metabolism*
  • Sleep Apnea, Obstructive / physiopathology*
  • Sleep Stages / drug effects
  • Vasoconstriction / drug effects*

Substances

  • Adrenergic alpha-Antagonists
  • Receptors, Adrenergic, alpha
  • Phentolamine